𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man

✍ Scribed by Vree, T. B. ;Beneken Kolmer, E. W. J. ;Martea, M. ;Bosch, R. ;Hekster, Y. A. ;Shimoda, M.

Publisher
Springer
Year
1990
Tongue
Dutch
Weight
948 KB
Volume
12
Category
Article
ISSN
1573-739X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics, acetylation-deacetylat
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in β€˜fast’ and β€˜slow’ acetylators
✍ Tom B. Vree; Chiel A. Hekster; Margriet Baakman; Tom Janssen; Marijn Oosterbaan; πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 825 KB

Sulphamerazine shows a clear acetylator phenotype. The half-life of elimination of sulphamerazine is 12 h in 'fast' and 24 h in 'slow' acetylators. N,-Acetylsulphamerazine is eliminated biphasically, characterized by half-lives of 5 and 12 h in 'fast' and 5 and 24 h in 'slow' acetylators. Protein b

Tissue distribution of N-acetyltransfera
Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster
✍ David W. Hein; Mark A. Doll; Donald E. Nerland; Adrian J. Fretland πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

## Abstract __N__‐acetyltransferase 1 (NAT1) and 2 (NAT2) enzymes catalyzing both deactivation (__N__‐acetylation) and activation (__O__‐acetylation) of arylamine carcinogens such as 4‐aminobiphenyl (ABP) were investigated in a Syrian hamster model congenic at the __NAT__2 locus. NAT2 catalytic act